Geneos Wealth Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-400
| Closed | -$7.42K | – | 2203 |
|
2023
Q3 | $7.42K | Hold |
400
| – | – | ﹤0.01% | 1642 |
|
2023
Q2 | $4.42K | Hold |
400
| – | – | ﹤0.01% | 1769 |
|
2023
Q1 | $5.37K | Hold |
400
| – | – | ﹤0.01% | 1705 |
|
2022
Q4 | $4.95K | Hold |
400
| – | – | ﹤0.01% | 1704 |
|
2022
Q3 | $5K | Hold |
400
| – | – | ﹤0.01% | 1712 |
|
2022
Q2 | $5K | Hold |
400
| – | – | ﹤0.01% | 2223 |
|
2022
Q1 | $6K | Hold |
400
| – | – | ﹤0.01% | 2304 |
|
2021
Q4 | $6K | Hold |
400
| – | – | ﹤0.01% | 2384 |
|
2021
Q3 | $6K | Hold |
400
| – | – | ﹤0.01% | 2421 |
|
2021
Q2 | $7K | Hold |
400
| – | – | ﹤0.01% | 2356 |
|
2021
Q1 | $7K | Hold |
400
| – | – | ﹤0.01% | 2563 |
|
2020
Q4 | $9K | Hold |
400
| – | – | ﹤0.01% | 2279 |
|
2020
Q3 | $16K | Hold |
400
| – | – | ﹤0.01% | 1775 |
|
2020
Q2 | $30K | Hold |
400
| – | – | ﹤0.01% | 1446 |
|
2020
Q1 | $26K | Hold |
400
| – | – | ﹤0.01% | 1407 |
|
2019
Q4 | $49K | Hold |
400
| – | – | ﹤0.01% | 1275 |
|
2019
Q3 | $25K | Hold |
400
| – | – | ﹤0.01% | 1518 |
|
2019
Q2 | $31K | Hold |
400
| – | – | ﹤0.01% | 1426 |
|
2019
Q1 | $44K | Sell |
400
-200
| -33% | -$22K | ﹤0.01% | 1213 |
|
2018
Q4 | $56K | Buy |
600
+100
| +20% | +$9.33K | ﹤0.01% | 1043 |
|
2018
Q3 | $63K | Buy |
500
+100
| +25% | +$12.6K | ﹤0.01% | 1064 |
|
2018
Q2 | $33K | Hold |
400
| – | – | ﹤0.01% | 1246 |
|
2018
Q1 | $24K | Hold |
400
| – | – | ﹤0.01% | 1322 |
|
2017
Q4 | $23K | Hold |
400
| – | – | ﹤0.01% | 1336 |
|
2017
Q3 | $23K | Buy |
+400
| New | +$23K | ﹤0.01% | 1274 |
|